These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20022791)

  • 1. [Which hormones promote breast cancer in postmenopause: estrogens, progestins, insulin and/or adipocytokines?].
    Jamin C
    Gynecol Obstet Fertil; 2010 Jan; 38(1):1-3. PubMed ID: 20022791
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.
    Perrier S; Caldefie-Chézet F; Vasson MP
    FEBS Lett; 2009 Jan; 583(2):259-65. PubMed ID: 19111549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Metabolism of steroid hormones by the human mammary gland in vivo and in vitro.
    Deshpande N; Carson P
    J Endocrinol; 1974 May; 61(2):liii=liv. PubMed ID: 4835919
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of various progestogens on metabolic risk factors for breast cancer.
    Campagnoli C; Abbà C; Ambroggio S; Lotano MR; Peris C
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():22-31. PubMed ID: 17943536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogens and progestins in relation to human cancer.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Dec; 21():83-129. PubMed ID: 397183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone-sensitive tumors of the female genitalia].
    Rendina GM
    Minerva Ginecol; 1975 Feb; 27(2):148-57. PubMed ID: 1134672
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestins in the menopause in healthy women and breast cancer patients.
    Pasqualini JR
    Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase in the central nervous system.
    Naftolin F; MacLusky NJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3274s-3276s. PubMed ID: 7083185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pomegranate and breast cancer: possible mechanisms of prevention.
    Sturgeon SR; Ronnenberg AG
    Nutr Rev; 2010 Feb; 68(2):122-8. PubMed ID: 20137057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone, progestins, pregnancy and breast cancer risk.
    Ferretti G
    Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.
    Muti P
    Ann N Y Acad Sci; 2004 Dec; 1028():273-82. PubMed ID: 15650252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Vigneri R; Frasca F; Sciacca L; Vigneri P; Frittitta L
    J Natl Cancer Inst; 2009 Jul; 101(14):1030-1; author reply 1031-2. PubMed ID: 19546433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.